由|可能会套新的Sohu Health |周Yichuan编辑| Yuan Yue是最近的第15次北京大学消化肿瘤论坛和中国胃肠道肿瘤临床研究合作小组（CGOG）年会在北京举行。会议的主题为“创新，准确性和聚会”。它基于对消化系统肿瘤研究的准确诊断和治疗和转化，重点关注最新的发展和研究方向，在临床实践中收集困难和热点，并积极促进现代诊断和治疗模型以及新的研究和发展。 CGOG会议主席，北京大学癌症医院教授Shen Lin在讲话中指出，胃肠道肿瘤治疗领域正在发生不变的变化。随着新的Tecnology，新的靶标和新药物的持续出现，我们从不间断的机会开始，但我们也面临着MORE挑战。在会议报告期间，国家蛋白质科学中心主席Fuchu首先介绍了人类蛋白质组导航计划（π-HUB计划），并解释了基本的科学目标和实施计划。该项目旨在通过蛋白质组的复杂性和动态来揭示生命系统的结构和功能基础。 π-Hub程序的第一个任务是人类蛋白质中与生命有关的信息，该信息设定了四个主要目标：扩展全文
首先，绘制男人的层次结构蛋白质组的地图；其次，开发蛋白质组状态状态的图并监测蛋白质光谱线。第三，建立Ametahuman数字模型以对人类结构进行数字识别；第四，在蛋白质组状态下导航，以预测疾病的状态，预测疾病风险，并警告亚健康和主要疾病。
此外，借助“ Xiyan”大型科学设施平台，它是计划促进全球研究前的种子项目，并以消化道肿瘤为主要方向。 The advent of the age of the drug accuracy for tumors driven by proteomics has brought significant successes and benefits to the diagnosis and treatment of diseases such as digestive tract tumors.
Next, Professor Shen Lin pointed out in his main speech on "exploration and application of accurate treatment techniques for the upper gastroenterology tumors" that the upper gastrointestinal tumors are harmful to KChinese people's health and lack of treatment methods. Currently, we propose to explore new treatment plans through the "B to B" two-way model of research model, that is, to explore new treatment plans for targets such as the HER2, EGFR and CLDN18.2. At the same time, cell therapy has shown its strengths in the field of solid tumors, and immunotherapy is also developed from 1.0 era to 2.0 era, which significantly expands the population of people benefiting from thE上胃肠道肿瘤免疫疗法。
The complexity of the microen environment of the upper gastrointestinal tumors requires us to deeply explore the essence of tumor heterogeneity from multiple sizes, accurately assemble the beneficiaries of targeted treatment, and strengthen chemoemic monitoring;在实体瘤治疗中的CAR -T有效性改善已成为立即需要研究的重要主题。 Generally, by building a full-chain two-way research system for clinical-changing-lash full-chain, the clinical transformation and application of accurate treatment of the upper gastrointestinal tumors can be more effectively promoted.回到Sohu看看更多